Jason Luke, MD, FACP, is an associate professor of medicine in the Division of Hematology/Oncology and the director of the Cancer Immunotherapeutics Center within the UPMC Hillman Cancer Immunology and Immunotherapy Program. Dr. Luke has a clinical focus on the care of patients with melanoma as well as patients with other cancers whose disease has progressed beyond standard therapy. Dr. Luke is an active researcher in melanoma, including uveal melanoma and cancer immunotherapy for solid tumors.

Dr. Luke is board-certified in internal medicine and medical oncology. He received his medical degree from Rosalind Franklin University of Medicine and Science/Chicago Medical School in North Chicago. Dr. Luke completed an internship and residency in internal medicine at Boston University Medical Center, followed by fellowships in medicine and medical oncology at Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York.

Dr. Luke has been the leader of the Melanoma Committee for the American Society of Clinical Oncology and has held leadership positions within the Society for Immunotherapy of Cancer. Dr. Luke is a member of the Melanoma Committee of the Eastern Cooperative Oncology Group and the Experimental Therapeutics Committee of the Alliance for Clinical Trials in Oncology. Dr. Luke is also a member of the American Association for Cancer Research and Society for Melanoma Research.